a 135 (Trilipix 135 mg)

Generic Name: fenofibric acid

Pill with imprint a 135 is Blue & Yellow, Capsule-shape and has been identified as Trilipix 135 mg. It is supplied by Abbott Laboratories.

Trilipix is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Trilipix 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for a 135

Trilipix

Generic Name: fenofibric acid
Imprint: a 135
Strength: 135 mg
Color: Blue & Yellow
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Abbott Laboratories
Inactive Ingredients: hydroxypropyl cellulose, methacrylic acid - ethyl acrylate copolymer (1:1) type a, povidone, water, silicon dioxide, sodium stearyl fumarate, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, FD&C Blue No. 2, ferric oxide yellow, hypromelloses
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00074-9189 (Discontinued)	Abbott Laboratories
00115-1460 (Discontinued)	Global Pharmaceuticals
68382-0078 (Discontinued)	Zydus Pharmaceuticals (USA) Inc.
54868-5986 (Discontinued)	Physicians Total Care Inc. (repackager)